Living Stone blog 3

 

 

All Posts

Living Stone achieves Veeva Vault PromoMats certification

“Review & approval” certification means full support for Living Stone customers using the Veeva Vault PromoMats digital asset management system.

Two members of the Living Stone team have earned the “Review & Approval” certification from Veeva Vault (picture taken before Corona outbreak), meaning they can now fully support customers who are using the Veeva Vault PromoMats digital asset management system for the life sciences sector.

Anne-Mie Vansteelant, Living Stone COO, and Bart Plaete, Digital Marketeer, earned the certification in February. Vault PromoMats combines digital asset management with review and distribution capabilities, providing the only solution built for life sciences. Easy review and approval, plus automated content distribution and withdraw across channels ensures complete visibility and control of all your materials.

 

Vault PromoMats Certification Program

The Vault PromoMats Certification Program provides training, certification, and support to agency individuals involved in the preparation and submission of commercial content (print or digital) for Vault PromoMats medical, legal and regulatory customers’ review and approval.

 

Complexities and challenges of creating marketing material within stringent medical, regulatory and legal frameworks

“We work side-by-side with our customers in life sciences and healthcare, and we understand the complexities and challenges of creating marketing material within stringent medical, regulatory and legal frameworks,” says Anne-Mie.

“By achieving our PromoMats certification for Review & Approval, we can support our customers even more comprehensively, aligning with all requirements and streamlining the review and approval processes.”

 

More than 400 life sciences companies across 165+ countries rely on Veeva Vault PromoMats for commercial content and digital asset management.

In addition to the Veeva Vault PromoMats certification, Living Stone is also a HubSpot Certified Partner, a Showpad Solutions Partner, and a Hashting Partner.

At Living Stone, we specialize in marketing strategies for healthcare. If you’d like to strengthen your marketing programs, or learn more about aligning your programs with your customers’ pain points, contact Anne-Mie Vansteelant at Living Stone, at +32 55 591 007 or anne-mie.vansteelant@livingstone.eu.

Living-Stone-CTA-Blog (002)

Anne-Mie Vansteelant
Anne-Mie Vansteelant
COO | Managing Partner at Living Stone

Related Posts

Meet MUM: Google’s new game-changing algorithm

Some updates to Google’s algorithm have a bigger impact than others. With the rollout of BERT (Bidirectional Encoder Representations from Transformers) in 2019, Google’s algorithms went from simply understanding words to being able to understand the context that the words were in. For example, think about how the meaning of the word “bank” differs in these sentences: I am going to the bank. / I am standing on the bank of the river. Thanks to the BERT algorithm, Google recognizes these nuances, and is able to provide search results that more closely align with the subject being searched for, providing the searcher with information that is more relevant.

Customer lifetime value emerges as top KPI

According to the experts at Marketo, marketers can expect to see a significant shift in marketing priorities over the next couple of years. The marketing automation company surveyed over 700 marketing execs and CEOs for their views on how marketing KPIs, required skillsets and technology tools will change by the year 2025. The surveyed marketers ranked customer retention, lead generation and customer lifetime value as their top three KPIs today (in that order). By 2025, they forecast that the order will switch, with customer lifetime value taking the lead at spot number one, followed by customer retention at number two (and lead generation will drop down to spot number six.)

Commercializing a new medical device? 3 critical success factors to consider

Launching a new medical device is a complicated process. First, of course, you have to come up with a concept. What do you want your technology to do, and how will it do it? There’s that initial period of blue-sky thinking and prototype development, where you refine your technology and determine whether it’s viable. Then, once you decide to move ahead with commercialization, and you’ve achieved your safety and efficacy goals, the pace picks up, and suddenly you’re on a fast track to your launch target date.